Serina Therapeutics (SER) Capital Expenditures (2018 - 2025)
Serina Therapeutics' (SER) quarterly Capital Expenditures came in at $13000.0 in Q3 2025, up 333.33% year-over-year from $3000.0 in Q3 2024, and down 71.74% quarter-over-quarter from $46000.0 in Q2 2025.
Powered by 
Analysis
Serina Therapeutics (SER) Capital Expenditures (2018 - 2025) Analysis & Trends
Serina Therapeutics has disclosed Capital Expenditures across 6 years of filings, most recently posting $13000.0 for Q3 2025.
- In Q3 2025, Capital Expenditures rose 333.33% year-over-year to $13000.0; the TTM figure through Dec 2025 stood at $59000.0 (up 168.18% YoY), while the FY2025 annual figure was $59000.0, up 168.18% from the prior year.
- Capital Expenditures came in at $13000.0 for Q3 2025 at Serina Therapeutics, down from $46000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $119000.0 in Q3 2023 to a low of $3000.0 in Q3 2024.
- Average Capital Expenditures over 3 years is $38571.4, with a median of $14000.0 recorded in 2024.
- Year-over-year, Capital Expenditures slumped 97.48% in 2024 and surged 333.33% in 2025.
- Over 3 years, Capital Expenditures stood at $70000.0 in 2023, then tumbled by 92.86% to $5000.0 in 2024, then surged by 160.0% to $13000.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $13000.0 in Q3 2025, $46000.0 in Q2 2025, and $5000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 37.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.87 Mn |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 119,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 295,000.00 |
| Sep 30, 2019 | 237,000.00 |
| Jun 30, 2019 | 106,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Sep 30, 2018 | 8,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 1,000.00 |